Market Overview

Benzinga's Top Downgrades

Share:
Benzinga's Top Downgrades

Analysts at Piper Jaffray downgraded MAKO Surgical (NASDAQ: MAKO) from “overweight” to “neutral.” The target price for MAKO Surgical has been raised from $26 to $30. MAKO Surgical's shares closed at $29.70 yesterday.

Analysts at Barclays downgraded ARIAD Pharmaceuticals (NASDAQ: ARIA) from “overweight” to “underweight.” The target price for ARIAD Pharmaceuticals has been lowered from $25 to $4. ARIAD Pharmaceuticals' shares closed at $5.83 yesterday.

Nomura downgraded Maxim Integrated Products (NASDAQ: MXIM) from “buy” to “neutral.” The target price for Maxim Integrated Products is set to $28. Maxim Integrated's shares closed at $29.22 yesterday.

Analysts at Ascendiant Capital downgraded Leapfrog Enterprises (NYSE: LF) from “buy” to “neutral.” The target price for Leapfrog Enterprises has been lowered from $12 to $8. Leapfrog's shares closed at $9.15 yesterday.

Latest Ratings for MAKO

DateFirmActionFromTo
Oct 2013PiperJaffrayDowngradesOverweightNeutral
Sep 2013Summer StreetDowngradesBuyNeutral
Sep 2013William BlairDowngradesOutperformMarket Perform

View More Analyst Ratings for MAKO
View the Latest Analyst Ratings

 

Related Articles (ARIA + MAKO)

View Comments and Join the Discussion!

Posted-In: Top DowngradesDowngrades Analyst Ratings

Latest Ratings

StockFirmActionPT
WKHSRoth CapitalMaintains15.0
HCKTRoth CapitalMaintains22.0
ARECRoth CapitalInitiates Coverage On7.5
SLABWells FargoMaintains180.0
PENWells FargoMaintains310.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com